45174
ASPEN TREASURY IRELAND LIMITED
Jun 30, 2021
South Africa
Africa
May 27, 2021
B - Limited
Active
Oct 5, 2021
Regional Industry - MAS Africa
other
Approved : May 27, 2021
Signed : Jun 30, 2021
Invested : Sep 30, 2021
other
The proposed investment is an up to EUR600 million (approximately US$723 million) financing package comprising (i) an unsecured, straight senior loan (“A” loan) of up to EUR200 million (approximately US$241 million) from IFC and; (ii) mobilization of “B” and/or parallel loans of up to EUR400 million (approximately US$482 million) to Aspen Finance Proprietary Limited (AFPL), a wholly owned subsidiary of Aspen Pharmacare Holdings Limited (Aspen or the Company). The financing will help Aspen, South Africa’s largest pharmaceutical company, to refinance existing debt and strengthen the Company’s balance sheet, supporting Aspen’s operations including production of vaccines, and other therapies in African and emerging markets.
For Inquiries About the Project, Contact
For Inquiries and Comments About IFC, Contact
Local Access of Project Documentation
IFC Communications, 2121 Pennsylvania Avenue, NW, Washington DC 20433
Telephone: 202-473-3800
Fax: 202-974-4384